Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P240005/S009

enVista Envy Hydrophobic Acrylic Intraocular Lens

Bausch + Lomb, Inc. · Decision date Oct 14, 2026

MEDTECHLEDGER EXPLANATIONP240005/S009

What did the FDA decide?

The FDA database lists P240005/S009 as a 30-day notice for Bausch & Lomb's enVista Envy hydrophobic acrylic intraocular lens (product code MFK, multifocal intraocular lens). The supplement reason is recorded as a process change involving the manufacturer, sterilizer, packager or supplier. The stated scope was increasing the production lot size and extending the unrefrigerated holding time.

The S009 identifier ties the notice to PMA P240005, but a supplement is not a new approval of the whole lens system, and this manufacturing notice is not the original PMA. The statement is reported purpose only, not independent proof of safety or clinical effectiveness. It gives no lot-size figures, holding-time limits, process details or supporting data, so those specifics remain absent. No new indication or clinical use is established here.

FDA approval order statement

increasing the production lot size and extending the unrefrigerated holding time
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Ophthalmic
Decision date
Oct 14, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P240005/S009
Regulatory pathway
PMA supplement
Product code
MFK
Decision code
OK30
Decision date
Oct 14, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Lens, multifocal intraocular.

Product code
MFK
FDA device class
3

For the original device and its historical approval scope, see PMA P240005. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P240005 · Original PMA

    enVista Envy hydrophobic acrylic intraocular lens (IOL), enVista Envy toric hydrophobic acrylic intraocular lens (IOL)

  2. P240005/S007 · Related supplement

    enVista Envy hydrophobic acrylic intraocular lens (IOL)

  3. P240005/S009 received

    Application receipt date recorded by FDA.

  4. P240005/S008 · Related supplement

    enVista Envy Hydrophobic Acrylic Intraocular Lens

  5. P240005/S009 · FDA decision

    30-Day Notice

  6. P240005/S010 · Related supplement

    enVista Envy Hydrophobic Acrylic Intraocular Lens

Timeline entries are records held by MedtechLedger for P240005. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P240005

Explore the linked device profile

Other records with product code MFK

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Bausch + Lomb, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
1400 N. Goodman St., Rochester, NY, 14609

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records